BOSTON SCIENTIFIC (BSX.SG)
BOSTON SCIENTIFIC (BSX.SG) operates in Diversified Metals & Mining.
BOSTON SCIENTIFIC (BSX.SG) (BSX) - Total Liabilities
Latest total liabilities as of September 2024: €17.12 Billion EUR
Based on the latest financial reports, BOSTON SCIENTIFIC (BSX.SG) (BSX) has total liabilities worth €17.12 Billion EUR as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
BOSTON SCIENTIFIC (BSX.SG) - Total Liabilities Trend (2016–2023)
This chart illustrates how BOSTON SCIENTIFIC (BSX.SG)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
BOSTON SCIENTIFIC (BSX.SG) Competitors by Total Liabilities
The table below lists competitors of BOSTON SCIENTIFIC (BSX.SG) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CYTOKINETICS
MU:KK3A
|
Germany | €1.45 Billion |
|
NKGen Biotech, Inc. Warrants
NASDAQ:NKGNW
|
USA | $85.36 Million |
|
Jade Leader Corp
PINK:MCKRF
|
USA | $453.20K |
|
ACME Lithium Inc
OTCQB:ACLHF
|
USA | $468.23K |
|
Tritax Big Box REIT plc
LSE:BBOX
|
UK | GBX2.35 Billion |
|
Evolution AB
STU:E3G1
|
Germany | €1.12 Billion |
Liability Composition Analysis (2016–2023)
This chart breaks down BOSTON SCIENTIFIC (BSX.SG)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.83 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BOSTON SCIENTIFIC (BSX.SG)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BOSTON SCIENTIFIC (BSX.SG) (2016–2023)
The table below shows the annual total liabilities of BOSTON SCIENTIFIC (BSX.SG) from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €15.61 Billion | +4.77% |
| 2022-12-31 | €14.90 Billion | -4.56% |
| 2021-12-31 | €15.61 Billion | +1.01% |
| 2020-12-31 | €15.45 Billion | -7.41% |
| 2019-12-31 | €16.69 Billion | +35.97% |
| 2018-12-31 | €12.27 Billion | +2.02% |
| 2017-12-31 | €12.03 Billion | +5.87% |
| 2016-12-31 | €11.36 Billion | -- |